The sell-off in India's insurtech names deepened on Thursday as investors continued to reassess the impact of the Insurance Regulatory and Development Authority of India's proposed overhaul of insurance distribution commissions, a move that has jolted the economics of online insurance broking and triggered a sharp repricing of the sector.
Shares of PB Fintech, the parent of Policybazaar, fell as much as 7.8% during the session to a fresh 52-week low of Rs 1,115.10 on the BSE before trimming losses later in the day. By the close, the stock ended 3.6% lower at Rs 1,165.50 apiece. Turtlemint, meanwhile, opened at its 20% lower circuit of Rs 87.30, which also marked a fresh all-time low, and remained locked at that level through the trading session. The stock later stayed pinned at the lower circuit, underscoring the intensity of the market's reaction.
The two-day rout has been severe. At prevailing prices during the session, PB Fintech shares had fallen about 39% across the two sessions since the sell-off began, while Turtlemint had declined about 35% from its level before the regulatory shock. PB Fintech's market capitalisation stood at Rs 53,128.6 crore, or about $5.5 billion, at 12:21 IST, while Turtlemint's market value was Rs 2,607.6 crore, or about $272 million.
The trigger was a consultation paper released by IRDAI on Wednesday that proposed product- and channel-specific commission ceilings for insurance distributors. The framework would reintroduce product-level commission caps more than three years after the regulator removed such limits in April 2023 and moved to an expenses of management, or EoM, framework. Under the new proposal, commissions would vary depending on the product, the distribution channel and the effort involved in selling and servicing a policy.
That distinction matters greatly for open-architecture digital distributors such as Policybazaar and Turtlemint's insurance broking arm. These platforms typically aggregate products from multiple insurers and rely on scale, digital acquisition and cross-selling to drive growth. Under the proposed regime, they would generally face lower commission caps than individual agents and some other distributors, potentially squeezing margins in categories such as health, motor and life insurance.
The market reaction reflects a broader fear that the proposals could force online brokers to rethink customer acquisition costs, incentive structures and long-term profitability. PB Fintech cofounder and group chairman Yashish Dahiya said on an investor call on Wednesday that the proposals had "almost forced" the company to consider entering insurance manufacturing, which would allow it to design, underwrite and sell policies itself. He added, however, that the company would wait for greater regulatory clarity before making any such move.
Brokerages quickly moved to quantify the possible damage. Bernstein described the proposed commission cuts as "much worse than imagined," warning that they could unravel PB Fintech's unit economics, particularly in health and motor insurance. Jefferies retained its Buy rating on PB Fintech but cut its price target to Rs 1,540 from Rs 2,050, estimating that a 10% reduction in new business commission rates could translate into a 10%-12% decline in earnings. It also flagged the proposals as a risk for Turtlemint.
Bank of America kept its Neutral rating on PB Fintech but lowered its target to Rs 1,410 from Rs 1,970, calling the proposals directionally negative for online insurance brokers while saying the impact on Policybazaar's life and term insurance businesses should remain manageable. Morgan Stanley also weighed in, saying the net present value of PB Fintech's business could be affected, though the full extent would depend on how the final rules are framed.
The consultation process is still underway, and the proposals are not final. IRDAI has invited stakeholder comments until October 25, leaving room for insurers, distributors and digital platforms to push back or seek modifications. Even so, the market's response suggests investors are already pricing in a more restrictive commission environment, one that could reshape how insurance is sold online in India and force the sector to adapt quickly to a less generous regulatory regime.